PyInvesting

Market research

EBO.AU EBOS Group Limited

AU AUD Healthcare

Latest close

16.61 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
4B
P/E ratio
14.57
Analyst target
23.0061
Dividend yield
5.8%
Beta
0.17

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

EBOS Group Limited is currently in a long term uptrend where the price is trading 11.7% above its 200 day moving average.

From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.

EBOS Group Limited's total revenue rose by 6.3% to $5B since the same quarter in the previous year.

Its net income has increased by 13.7% to $93M since the same quarter in the previous year.

Finally, its free cash flow grew by 96.7% to $45M since the same quarter in the previous year.

Based on the above factors, EBOS Group Limited gets an overall score of 5/5.